Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8268e39ce70ff2ad19742e2a21d5a90c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-31 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0089 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y115-01001 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2005-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2009-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d227ab76de7f13532c57a61e060a53a8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65cefc0d0a67e538febf19a3bee28257 |
publicationDate |
2009-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7498316-B2 |
titleOfInvention |
Methods and compositions for treating gain-of-function disorders using RNA interference |
abstract |
The present invention relates to novel methods for treating dominant gain-of-function diseases. The invention provides methods for targeting regions of the copper zinc superoxide dismutase (SOD1), which causes inherited amyotrophic lateral sclerosis (ALS), with RNAi agent. The invention further provides RNAi resistant replacement genes containing mismatches with their respective RNAi agent s. The invention also provides for vectors that express RNAi agent and RNAi resistant replacement gene of the present invention. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10954518-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11434502-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10851375-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11760999-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11739330-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020010042-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10711274-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11603542-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019079240-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019079242-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015161184-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11505807-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10793861-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11542506-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10513710-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10280418-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4124658-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11649459-B2 |
priorityDate |
2004-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |